S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Silicon Motion Proves That AI in Motion Stays in Motion
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Silicon Motion Proves That AI in Motion Stays in Motion
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Silicon Motion Proves That AI in Motion Stays in Motion
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Silicon Motion Proves That AI in Motion Stays in Motion
NYSE:HLN

Haleon (HLN) Stock Price, News & Analysis

$8.10
+0.04 (+0.50%)
(As of 04/16/2024 ET)
Today's Range
$8.06
$8.15
50-Day Range
$8.03
$8.65
52-Week Range
$7.70
$9.05
Volume
5.21 million shs
Average Volume
5.58 million shs
Market Capitalization
$36.99 billion
P/E Ratio
28.93
Dividend Yield
2.59%
Price Target
N/A

Haleon MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
0.55% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.62mentions of Haleon in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.51%
From $0.47 to $0.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.18 out of 5 stars

Medical Sector

791st out of 930 stocks

Toilet Preparations Industry

12th out of 13 stocks

HLN stock logo

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

HLN Stock News Headlines

Stocks Making Big Moves Today
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Pfizer Plans To Sell About 630 Mln Haleon Shares
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Haleon plc (HLN) Q4 2023 Earnings Call Transcript
Haleon plc 2023 Q4 - Results - Earnings Call Presentation
Zoetis Inc. (ZTS)
1 Pharma Stock to Buy Near 52-Week Highs
GSK to sell 3.2% stake in spin-off Haleon
Peering Into Haleon's Recent Short Interest
See More Headlines
Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend
3/14/2024
Today
4/16/2024
Next Earnings (Estimated)
5/01/2024
Dividend Payable
5/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Toilet preparations
Sub-Industry
N/A
Fax
N/A
Employees
25,408
Year Founded
N/A

Profitability

Net Income
$1.30 billion
Pretax Margin
14.40%

Debt

Sales & Book Value

Annual Sales
$14.05 billion
Cash Flow
$0.37 per share
Book Value
$4.51 per share

Miscellaneous

Outstanding Shares
4,566,150,000
Free Float
N/A
Market Cap
$36.99 billion
Optionable
Not Optionable
Beta
0.29
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Brian James McNamara (Age 58)
    CEO & Executive Director
    Comp: $4.28M
  • Mr. Tobias Hannes Hestler (Age 52)
    CFO & Executive Director
    Comp: $2.38M
  • Ms. Sonya Ghobrial (Age 50)
    Head of Investor Relations
  • Mr. Bjarne Philip Tellmann (Age 57)
    General Counsel
  • Ms. Tamara Rogers (Age 54)
    Chief Marketing Officer
  • Ms. Mairead Nayager (Age 49)
    Chief Human Resources Officer
  • Mr. Filippo Lanzi
    President of EMEA & LatAm
  • Mr. Keith Choy (Age 55)
    President of Asia Pacific
  • Ms. Lisa Paley (Age 57)
    President of North America
  • Mr. Franck Riot (Age 56)
    Chief R&D Officer

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc has shown consistent growth in its stock price, trading at $8.43 recently, with a market capitalization of $38.92 billion.
  • The company has a diverse product portfolio, including consumer healthcare products in various regions globally, providing revenue stability.
  • Recent institutional investments from reputable firms like Wellington Management Group LLP and Douglas Lane & Associates LLC indicate confidence in Haleon's future prospects.
  • Haleon plc has a low debt-to-equity ratio of 0.53, indicating a healthy financial structure and lower risk.
  • The company's dividend payout ratio of 75.00% suggests a commitment to rewarding shareholders with consistent dividends.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

  • The stock price of Haleon plc has shown minimal growth, with fluctuations around the $8 range, potentially limiting short-term capital gains.
  • Despite recent institutional investments, increased competition in the consumer healthcare industry could impact Haleon's market share and profitability.
  • The company's P/E ratio of 30.14 suggests the stock may be overvalued compared to industry peers, posing a risk of a price correction.
  • Haleon plc's P/E/G ratio of 2.17 indicates a higher valuation relative to its earnings growth rate, potentially signaling an inflated stock price.
  • Investors should consider the company's beta of 0.30, indicating lower volatility compared to the market average, which may limit potential returns in highly volatile market conditions.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings
or view top-rated stocks.

How have HLN shares performed in 2024?

Haleon's stock was trading at $8.23 on January 1st, 2024. Since then, HLN stock has decreased by 1.6% and is now trading at $8.10.
View the best growth stocks for 2024 here
.

Are investors shorting Haleon?

Haleon saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 25,360,000 shares, an increase of 21.9% from the March 15th total of 20,810,000 shares. Based on an average daily volume of 5,650,000 shares, the days-to-cover ratio is presently 4.5 days. Approximately 0.6% of the company's shares are sold short.
View Haleon's Short Interest
.

When is Haleon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our HLN earnings forecast
.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon declared a semi-annual dividend on Thursday, February 29th. Stockholders of record on Friday, March 15th will be paid a dividend of $0.1064 per share on Thursday, May 16th. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 14th.
Read our dividend analysis for HLN
.

Is Haleon a good dividend stock?

Haleon (NYSE:HLN) pays an annual dividend of $0.21 per share and currently has a dividend yield of 2.66%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLN will have a dividend payout ratio of 41.18% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HLN.

What ETFs hold Haleon's stock?

ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), ClearBridge Focus Value ESG ETF (CFCV) and Pacer BioThreat Strategy ETF (VIRS).Horizon Kinetics Medical ETF (MEDX).

Who are Haleon's major shareholders?

Haleon's stock is owned by a number of institutional and retail investors. Top institutional investors include Douglas Lane & Associates LLC (0.18%), First Hawaiian Bank (0.01%), Keystone Financial Planning Inc. (0.01%), Procyon Advisors LLC (0.00%), Cohen Klingenstein LLC (0.00%) and Park Avenue Securities LLC (0.00%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners